Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1298, Japan.
Surg Endosc. 2024 Jul;38(7):3887-3904. doi: 10.1007/s00464-024-10937-1. Epub 2024 Jun 3.
Laparoscopic liver resection (LLR) is rapidly gaining popularity; however, its efficacy for nonalcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) (NAFLD-HCC) has been not evaluated. The purpose of this study was to compare short- and long-term outcomes between LLR and open liver resection (OLR) among patients with NAFLD-HCC.
We used a single-institution database to analyze data for patients who underwent LLR or OLR for NAFLD-HCC from January 2007 to December 2022. We performed propensity score-matching analyses to compare overall postoperative complications, major morbidities, duration of surgery, blood loss, transfusion, length of stay, recurrence, and survival between the two groups.
Among 210 eligible patients, 46 pairs were created by propensity score matching. Complication rates were 28% for OLR and 11% for LLR (p = 0.036). There were no significant differences in major morbidities (15% vs. 8.7%, p = 0.522) or duration of surgery (199 min vs. 189 min, p = 0.785). LLR was associated with a lower incidence of blood transfusion (22% vs. 4.4%, p = 0.013), less blood loss (415 vs. 54 mL, p < 0.001), and shorter postoperative hospital stay (9 vs. 6 days, p < 0.001). Differences in recurrence-free survival and overall survival between the two groups were not statistically significant (p = 0.222 and 0.301, respectively).
LLR was superior to OLR for NAFLD-HCC in terms of overall postoperative complications, blood loss, blood transfusion, and postoperative length of stay. Moreover, recurrence-free survival and overall survival were comparable between LLR and OLR. Although there is a need for careful LLR candidate selection according to tumor size and location, LLR can be regarded as a preferred treatment for NAFLD-HCC over OLR.
腹腔镜肝切除术(LLR)迅速普及;然而,其在非酒精性脂肪性肝病(NAFLD)相关肝细胞癌(HCC)(NAFLD-HCC)中的疗效尚未得到评估。本研究旨在比较 LLR 和开腹肝切除术(OLR)治疗 NAFLD-HCC 患者的短期和长期结局。
我们使用单机构数据库分析了 2007 年 1 月至 2022 年 12 月期间接受 LLR 或 OLR 治疗的 NAFLD-HCC 患者的数据。我们进行了倾向评分匹配分析,以比较两组患者的总体术后并发症、主要并发症、手术时间、失血量、输血、住院时间、复发和生存情况。
在 210 名符合条件的患者中,通过倾向评分匹配创建了 46 对。OLR 的并发症发生率为 28%,而 LLR 的并发症发生率为 11%(p=0.036)。主要并发症(15%比 8.7%,p=0.522)或手术时间(199 分钟比 189 分钟,p=0.785)无显著差异。LLR 与较低的输血发生率(22%比 4.4%,p=0.013)、较少的失血量(415 比 54 毫升,p<0.001)和较短的术后住院时间(9 比 6 天,p<0.001)相关。两组患者的无复发生存率和总生存率差异无统计学意义(p=0.222 和 0.301)。
在总体术后并发症、失血量、输血和术后住院时间方面,LLR 优于 OLR 治疗 NAFLD-HCC。此外,LLR 与 OLR 的无复发生存率和总生存率相当。尽管需要根据肿瘤大小和位置仔细选择 LLR 候选者,但与 OLR 相比,LLR 可作为治疗 NAFLD-HCC 的首选方法。